You have accessJournal of UrologySurgical Technology & Simulation: Instrumentation & Technology II (MP43)1 May 2024MP43-07 THE RADPAD: EVALUATION OF A NOVEL LEAD-FREE RADIATION PROTECTION SHIELD AND COMPARISON TO CONVENTIONAL LEAD APRON Jammie-Lyn Quines, Katya Hanessian, Ala'a Farkouh, Ruben Crew, Uy Lae Kim, Grant Sajdak, D. Daniel Baldwin, Akin S. Amasyali, Sikai Song, Kai Wen Cheng, Evan Seibly, Zhamshid Okhunov, and D. Duane Baldwin Jammie-Lyn QuinesJammie-Lyn Quines , Katya HanessianKatya Hanessian , Ala'a FarkouhAla'a Farkouh , Ruben CrewRuben Crew , Uy Lae KimUy Lae Kim , Grant SajdakGrant Sajdak , D. Daniel BaldwinD. Daniel Baldwin , Akin S. AmasyaliAkin S. Amasyali , Sikai SongSikai Song , Kai Wen ChengKai Wen Cheng , Evan SeiblyEvan Seibly , Zhamshid OkhunovZhamshid Okhunov , and D. Duane BaldwinD. Duane Baldwin View All Author Informationhttps://doi.org/10.1097/01.JU.0001008720.96896.83.07AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Percutaneous nephrolithotomy (PCNL) routinely requires fluoroscopy which exposes the surgeon to ionizing radiation. Standard lead aprons and thyroid shields do not protect the head, arms, and legs. The RADPAD® is a novel lead-free shield that can be positioned directly in the surgical field to block scatter radiation. The primary objective of this study was to assess the effectiveness and added protection of the RADPAD® compared to conventional lead. METHODS: To simulate a PCNL, a radiographic phantom patient and a mannequin surgeon were utilized (Figure 1a). Using a real-time dosimeter, radiation doses were measured in μSv at seven distinct anatomical locations on the surgeon: head, neck, chest, abdomen, pelvis, forearm, and leg. Three shielding devices were evaluated (Figure 1b): a conventional lead apron with a thyroid shield (LATS), a double-thickness RADPAD® (R2), and a triple-thickness RADPAD® (R3). The effectiveness of combining LATS with R2 or R3 was also examined and compared to baseline (no lead). Five trials of five seconds of fluoroscopy were conducted for each site and shielding combination. The Mann-Whitney U test was used to compare exposures with p<0.05 significant. RESULTS: LATS alone significantly reduced radiation exposure at all protected sites compared to baseline, reaching reductions>95% (p<0.05). There was no protection by LATS to the head, forearm, and leg of the surgeon. Use of R2 or R3 alone significantly reduced radiation at all tested sites (p<0.05) compared to baseline, except the legs. Compared to LATS alone, use of R2 or R3 significantly reduced radiation exposure to the head (up to 48%) and forearm (up to 84%; p<0.05). Combining LATS with R3 resulted in the greatest reduction in radiation, performing significantly better than LATS alone at the head, pelvis, and forearm (p<0.05). No single shielding device or combination significantly reduced radiation exposure to the legs. CONCLUSIONS: The LATS alone reduced radiation>95% at shielded sites, but provided no protection to the head, forearm, and leg. Addition of the RADPAD® to conventional LATS functions as an effective and novel strategy that reduces radiation exposure at all measured sites except the legs, and provides important protection to the head and arms of the surgeon without increasing the weight burden. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e695 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Jammie-Lyn Quines More articles by this author Katya Hanessian More articles by this author Ala'a Farkouh More articles by this author Ruben Crew More articles by this author Uy Lae Kim More articles by this author Grant Sajdak More articles by this author D. Daniel Baldwin More articles by this author Akin S. Amasyali More articles by this author Sikai Song More articles by this author Kai Wen Cheng More articles by this author Evan Seibly More articles by this author Zhamshid Okhunov More articles by this author D. Duane Baldwin More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Quines et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: